Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-10-26FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2018-10-26FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.…
-
FDA approval · 2018-10-26FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharmaceu…
-
FDA approval · 2018-10-26FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY XR (empagliflozin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceutical…
-
FDA label_change · 2018-10-26FDA Approved: STEGLUJAN — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Steglujan (ertugliflozin and sitagliptin) from Merck Sharp & Dohme LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-10-25FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Toujeo (insulin glargine) filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2018-10-25FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approves a supplemental application for AFREZZA (insulin human) from MannKind Corporation.
-
CLINICAL_TRIALS research · 2018-10-25Clinical Trial Update: Diet, Obesity and Genes (DiOGenes) [Phase 4]
Phase 4 clinical trial update on Diet, Obesity and Genes (DiOGenes) studying obesity and metabolic syndrome.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing IDegLira versus insulin glargine as add-on to SGLT2 inhibitors in type 2 diabetes; completed with results posted in …
-
FDA approval · 2018-10-22FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic metformin hydrochloride product under an Original Application (ANDA206145) from Ascend Laboratories, LLC.
-
FDA approval · 2018-10-19FDA Approved: ADMELOG — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for ADMELOG (insulin lispro) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone [Phase 3]
A Phase 3 trial comparing saxagliptin with dapagliflozin plus metformin versus glimepiride with metformin in type 2 diabetes with inadequate…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: A Single Dose Study of LY2605541 in Participants With Liver Impairment [Phase 1]
Phase 1 single-dose study of LY2605541 in participants with hepatic impairment completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart [Phase 1]
Phase 1 study evaluating the effects of LY2409021 on cardiac electrical impulses in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India [NA]
A completed clinical trial update on the iPro2 device for real-world management of Type 2 diabetes in India with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of PF-06293620 in subjects with type 2 diabetes mellitus completed.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan [Phase 4]
A Phase 4 clinical trial update on treating Type 2 diabetes with a long-acting basal insulin conducted in Jordan has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838) [Phase 3]
Phase 3 trial comparing adding sitagliptin versus adding dapagliflozin to metformin in type 2 diabetes with mild renal impairment and inadeq…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes [Phase 3]
A Phase III trial evaluating saxagliptin co-administered with dapagliflozin as add-on therapy to metformin in type 2 diabetes with inadequat…
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: RISE Pediatric Medication Study [Phase 3]
A Phase 3 clinical trial update for the RISE pediatric study on a medication for prediabetes and type 2 diabetes has completed with results …
-
FDA approval · 2018-10-05FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved a generic Colesevelam Hydrochloride (colesevelam hydrochloride) via an Original Application filed by Dr. Reddy's Laboratories I…
-
FDA approval · 2018-10-05FDA Approved: COLESEVELAM HCL — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' Colesevelam HCl (generic) under ANDA209038. The drug is a bile acid sequestrant indicated to reduce LDL ch…
-
CLINICAL_TRIALS research · 2018-10-04Clinical Trial Update: Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population [Phase 4]
Phase 4 trial examining the relationship between periodontal disease treatment and management of type 2 diabetes in the Gullah population.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes [Phase 3]
Phase 3 clinical trial update for YH14755 in adults with dyslipidemia and type II diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Study of LY2608204 in Patients With Type 2 Diabetes [Phase 1]
Phase 1 clinical trial update for LY2608204 in patients with Type 2 diabetes; study completed with results posted in 2018.